ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1932

Complications Following Total Knee Arthroplasty in Inflammatory Versus Osteoarthritis

Shawn Richardson1, William Schairer1, Cynthia Kahlenberg2, Thomas P. Sculco3, Peter K. Sculco3, Linda A. Russell4, Susan M. Goodman2 and Mark P. Figgie5, 1Hospital for Special Surgery, new york, NY, 2Hospital for Special Surgery, New York, NY, 3Orthopaedic Surgery, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 4Rheumatology, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 5Surgery, Hospital for Special Surgery, New York, NY

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: inflammatory arthritis, osteoarthritis and outcomes, Total Knee Arthroplasty (TKA)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, October 22, 2018

Title: 4M105 ACR Abstract: RA–DX, Manifestations, & Outcomes III: Diagnosis & Prognosis II (1929–1934)

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: TKA is commonly performed in patients with a history of inflammatory arthritis. These patients are likely at higher risk of complications, from both the underlying disease and immunosuppressive medications. The purpose of this study was to perform a population-based comparison of the risk of postoperative complications between patients with inflammatory arthritis and osteoarthritis.

Methods: A national private insurance database was used to select patients undergoing unilateral primary TKA. Patients were categorized to the inflammatory cohort if they had an ICD diagnosis of inflammatory arthritis as well as treatment with a DMARD, biologic, or SLE-specific medication within the year prior to surgery. Patients with no diagnosis of inflammatory arthritis were assigned to osteoarthritis. Postoperative complications were identified using Reportable CMS Complication Measures. Risk of each complication was compared between cohorts using multivariate logistic regression controlling for age, gender, length of stay, comorbidities, and use of corticosteroids within 3 months prior to TKA.

Results: 137,550 patients were included; 2.23% met criteria for inflammatory arthritis as described above. Independent of age, gender, LOS, comorbidities, and recent steroid use, inflammatory patients were found to have higher risk of transfusion (OR 1.39, p < 0.01), infection (OR 1.64, p < 0.01), and readmission (OR 1.46, p < 0.01). There were no differences in risk of VTE, medical, or mechanical complications.

Conclusion: Independent of other comorbidities, patients with inflammatory arthritis are at high risk of transfusion, infection, and readmission. Treatment of these patients is likely more costly and efforts should be made to optimize their health and treatment medications prior to TKA to minimize their complication risk. Additionally, these results have important implications for evolving bundled payment models. Hospitals should receive commensurate resources to maintain access to TKA for patients with inflammatory arthritis that are prone to higher resource utilization.


Disclosure: S. Richardson, None; W. Schairer, None; C. Kahlenberg, None; T. P. Sculco, Exactech, Inc., 7,Lima Corporate, 5; P. K. Sculco, Lima, 5; L. A. Russell, None; S. M. Goodman, Roche, Novartis, 4; M. P. Figgie, None.

To cite this abstract in AMA style:

Richardson S, Schairer W, Kahlenberg C, Sculco TP, Sculco PK, Russell LA, Goodman SM, Figgie MP. Complications Following Total Knee Arthroplasty in Inflammatory Versus Osteoarthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/complications-following-total-knee-arthroplasty-in-inflammatory-versus-osteoarthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/complications-following-total-knee-arthroplasty-in-inflammatory-versus-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology